2-2-5-5-tetramethyl-1-pyrrolidinyloxy-3-carboxylic-acid has been researched along with Neoplasms* in 1 studies
1 other study(ies) available for 2-2-5-5-tetramethyl-1-pyrrolidinyloxy-3-carboxylic-acid and Neoplasms
Article | Year |
---|---|
Amphiphilic branched polymer-nitroxides conjugate as a nanoscale agent for potential magnetic resonance imaging of multiple objects in vivo.
In order to address the potential toxicity of metal-based magnetic resonance imaging (MRI) contrast agents (CAs), a concept of non-metallic MRI CAs has emerged. Currently, paramagnetic nitroxides (such as (2,2,5,5-tetramethylpyrrolidine-1-oxyl, PROXYL), (2,2,6,6-tetramethylpiperidine-1-oxide, TEMPO), etc.) are being extensively studied because their good stability and imaging mechanism are similar to metal-based contrast agents (such as Gd. Branched pDHPMA-mPEG-Ppa-PROXYL with a high molecular weight (MW = 160 kDa) and a nitroxides content (0.059 mmol/g) can form a nanoscale (~ 28 nm) self-assembled aggregate in a water environment and hydrophobic PROXYL can be protected by a hydrophilic outer layer to obtain strong reduction resistance in vivo. Compared with a small molecular CA (3-Carboxy-PROXYL (3-CP)), Branched pDHPMA-mPEG-Ppa-PROXYL displays three prominent features: (1) its longitudinal relaxivity (0.50 mM. As a safe and efficient candidate metal-free magnetic resonance contrast agent, Branched pDHPMA-mPEG-Ppa-PROXYL is expected to be used not only in imaging the tumor, liver and kidney, but also the cardiovascular system, which expands the application scope of these CAs. Topics: Animals; Cell Survival; Contrast Media; Cyclic N-Oxides; Female; Gadolinium; Heart; Kidney; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Nitrogen Oxides; Polymers | 2021 |